Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Lundberg et al., 2001
Results also showed that patients taking afamelanotide experienced less severe phototoxic reactions and had an improved quality of life after receiving the drug
Trials have shown weight loss of 15 percent to 20 percent, with around 40 percent of US adults classified as obese, based on data from the Centers for Disease Control and Prevention
In some embodiments, the otic formulation or composition comprises about 12% by weight of the poloxamer
Extended Protocol (24 Weeks): The longest clinical trial evaluated 24-week daily administration with doses of 0.25 mg, 0.5 mg, and 1 mg
Avoiding counterfeit products The peptide market includes both legitimate research suppliers and problematic vendors selling mislabeled or underdosed products
US$ 24.90
US$ 20.71
US$ 22.37
US$ 28.77
US$ 24.41
US$ 25.54
US$ 23.75
